Morning infusions may boost immunotherapy survival benefit, major analysis finds
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
Tag: overall survival
Two Decades of Data Show Steady Gains in Survival After Stem Cell Transplants for Leukemia
A national cohort study of 1,112 Austrian AML patients spanning 2000 to 2017 shows gradual improvements in five-year survival after ...
Hidden Statistical Bias May Have Inflated Immunotherapy Hopes in Mesothelioma Trial
A new analysis shows that post-progression censoring may have generated a misleading survival advantage for nivolumab in second-line mesothelioma, resolving ...
Biweekly Chemo Duo Shows Promise for Pancreatic Cancer Patients Over 75
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
Chemotherapy After Hormone Therapy Fails Leaves Metastatic Breast Cancer Patients With Grim Odds
A study of more than 5,000 US patients with HR-positive/HER2-negative metastatic breast cancer found median survival of only 13.5 months ...
Children With Down Syndrome Face 150-Fold Higher Leukemia Risk, and a Landmark Turkish Study Shows Why Getting the Diagnosis Right Saves Lives
A nationwide Turkish cohort study of 53 children with Down syndrome shows that those with Down syndrome-related myeloid leukemia achieved ...
Tumor Count and MELD Score Guide Surgery Choice for Intermediate Liver Cancer
A Taiwanese retrospective study shows that tumor number and MELD score can identify which intermediate-stage hepatocellular carcinoma patients benefit from ...
Lesser Lymph Node Surgery Matches Full Dissection for Node-Positive Breast Cancer Survival
A new study shows that targeted axillary dissection delivers equivalent recurrence, survival, and mortality outcomes compared with full axillary lymph ...
Liposomal Paclitaxel With HER-2 Blockers Shows Strong Real-World Results in Advanced Breast Cancer
A real-world study of 526 patients found that paclitaxel liposome combined with anti-HER-2 targeted therapies delivered median overall survival of ...
KRAS Mutation and Tumor Burden Power New Nomogram Defining Biologically Borderline Resectable Colorectal Liver Metastases
A Japanese multicenter study of 584 patients has developed a nomogram integrating KRAS mutation status, tumor burden score, nodal metastasis, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!